
AstraZeneca and Oracle will use AI and real patient health data to find people for drug trials faster, the two firms announced. The deal adds to a long list of AI health tie-ups between drugmakers and tech companies. The pair signed a non-binding term …

Pet owners who cannot face losing an animal now have a growing menu of biotech options. They range from longevity drugs to cloning and cryonics. MIT Technology Review laid out the options this week, and questioned whether some of them are wise. Pills f…

Anthropic president Daniela Amodei has warned that AI romantic partners risk driving people further apart, Business Insider reported. She spoke in a prerecorded interview with Arianna Huffington, founder and chief executive of Thrive Global. It was mad…

Google has taken a stake in Flo Health, the period-tracking app, the companies said on Monday. The multi-year deal will bring women’s health data into Google’s wearables and coaching. They did not disclose the size of the investment. From early 2027, u…
Could they be the next “eye” phone? I spoke with the founders of Xpanceo to find out.

NHS England’s South East region is rolling out an AI that can discharge patients with harmless skin lesions without a dermatologist seeing them. DERM, made by London-based Skin Analytics, goes live in all 18 NHS trusts there from this autumn. It will c…

Paris start-up Rivercell has raised a $25M seed round to build an AI model that predicts how human cells respond to drugs and genetic changes. HV led the round, with HCVC, Alven and Bpifrance Digital Venture taking part, the company said on Wednesday. …